Boston Scientific uses an internal AI-based omnichannel sales and marketing platform that analyzes data to deliver targeted educational messages and product information to physicians through the most relevant channel at the optimal time. Company executives publicly described this initiative at a February 2024 investor event.

The omnichannel platform aggregates customer touchpoint data from multiple channels (digital, in-person, events) and uses AI to determine what content to deliver to which physician, through which channel, and when. According to Boston Scientific group president Art Butcher, the platform is designed to reduce 'unnecessary duplication' in sales and marketing outreach while improving customer experience and sales representative efficiency. The company describes this as an internal commercial operations tool, not a customer-facing product.